COVID -19 Vaccination | Update – Day 406

ad
Measles Rubella vaccination 2nd phase campaign rolled out
Vaccination

India’s COVID-19 vaccination coverage has crossed 177 Crore landmark milestone (1,77,13,71,582) today. More than 25 lakh (25,20,820Vaccine Doses have been administered till 7 pm today. More than 1.98 Crore (1,98,39,419) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10401362
2nd Dose 9964386
Precaution Dose 4151565
FLWs 1st Dose 18409122
2nd Dose 17436719
Precaution Dose 6153048
Age Group 15-18 years 1st Dose 54603726
2nd Dose 26533036
Age Group 18-44 years 1st Dose 551493639
2nd Dose 442377408
Age Group 45-59 years 1st Dose 202223323
2nd Dose 179750438
Over 60 years 1st Dose 126367308
2nd Dose 111971696
Precaution Dose 9534806
Cumulative 1st dose administered 963498480
Cumulative 2nd dose administered 788033683
Precaution Dose 19839419
Total 1771371582

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 25th February, 2022 (406th Day)
HCWs 1st Dose 73
2nd Dose 1558
Precaution Dose 15048
FLWs 1st Dose 133
2nd Dose 2594
Precaution Dose 23406
Age Group 15-18 years 1st Dose 138935
2nd Dose 718359
Age Group 18-44 years 1st Dose 153500
2nd Dose 993174
Age Group 45-59 years 1st Dose 25733
2nd Dose 217170
Over 60 years 1st Dose 20887
2nd Dose 132937
Precaution Dose 77313
Cumulative 1st dose administered 339261
Cumulative 2nd dose administered 2065792
Precaution Dose 115767
Total 2520820

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply